Erratum: Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome (Cancer Cell (2019) 36(2) (123–138.e10), (S1535610819302983), (10.1016/j.ccell.2019.06.007))

(Cancer Cell 36, 123–138.e1–e10; August 12, 2019) As a result of an author oversight in the originally published version of this article, the first name of author Yasuhide Hayashi was misspelled as “Asuhide.” This error has now been corrected in the article online. In addition, middle initials have been added for authors Jeffrey W. Taub and Stefan N. Constantinescu. The authors apologize for the error and any inconvenience that may have resulted. Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down SyndromeLabuhn et al.Cancer CellJuly 11, 2019In BriefMyeloid leukemia in Down syndrome (ML-DS) evolves from transient abnormal myelopoiesis (TAM). Labuhn et al. show that trisomy 21 and GATA1 mutations are sufficient for the development of TAM. They further identify and functionally validate additional variants that drive TAM to ML-DS transformation. Full-Text PDF Open Archive